MDL Judge Reaffirms Ruling To Hold Off Discovery Into GLP-1 Marketing Plans

( October 28, 2024, 3:29 PM EDT) -- PHILADELPHIA — The Pennsylvania federal judge newly appointed to oversee the multidistrict litigation involving diabetes and diet drugs XE "diabetes and diet drugs"  that consumers allege cause gastrointestinal and other injuries declined to reconsider her case management order that barred the plaintiffs from pursuing discovery into the drug makers’ marketing campaigns....